Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of Hugel-Tox (Botulinum toxin A, Hugel, Korea) against
Botox in the treatment of Essential Blepharospasm and to get a regulatory approval from KFDA
Phase:
Phase 3
Details
Lead Sponsor:
Hugel
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA